Evaluation of Vitamin D and trace element level in sera of patients with Rheumatoid arthritis
DOI:
https://doi.org/10.22317/imj.v6i1.1114Keywords:
(1,25-(OH)2D3) , trace elements, Rheumatoid arthritis (RA)Abstract
Objective: The purpose of this research was to assess the serum concentration of (1,25-(OH)2D3) and trace elements in patients with rheumatoid arthritis as compared to healthy individuals.
Methods: This research was performed on 72participants, 37 cases of RA and 35 healthy individuals, with age range 39-67 years. Serum (1,25-(OH)2D3) levels was determined and compared in cases and healthy controls.
Results: The serum (1,25-(OH)2D3) levels were significantly lower in the RA patients (13.24 ± 1.06 ng/ml), when compared to the healthy individuals (26.9 ± 1.7 ng/ml). The examination of data revealed that the levels of (Magnesium, Manganese, Nickel and Rubidium) were remarkably elevated in RA patients when compared to healthy control , serum levels of (Chromium, Cobalt and Germanium) were remarkably decreased in RA patients when compared to healthy control.
Conclusions: (1,25-(OH)2D3) insufficiency is more widespread among patients with RA and may be one of the reasons leading to evolution of rheumatoid arthritis. Supplementation with (1,25-(OH)2D3) may be required both for the avoidance of bone loss besides for painkilling in patients suffering from rheumatoid arthritis. Current results propose that alterations in the serum concentration of trace elements may yield good indication to their role in the pathogenesis of rheumatoid arthritis.
References
Mason, R., Sequeira, V. and Gordon-Thomson, C. Vitamin D: the light side of sunshine. Eur J Clin Nutr 2011; 65: 986–993
Choy, E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheum 2012; 51: v3–v11.
Keystone, E., Smolen, J. and van Riel, P. Developing an effective treatment algorithm for rheumatoid arthritis. Rheum 2012; 51: v48–v54.
Sharma, P. and Pathak, K. Are biological targets the final goal for rheumatoid arthritis therapy? Expert Opin Biol Ther 2012; 12: 1611–1622.
Merlino, L., Curtis, J., Mikuls, T., Cerhan, J., Criswell, L. and Saag, K.; Iowa Women’s Health Study ,Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2012; 50: 72–77.
Cantorna MT Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000; 223: 230-233.
. Maruotti N, Cantatore FP .Vitamin D and the immune system. J Rheumatol 2010; 37: 491-495.
. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ .1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGFbeta. J Immunol 2008; 180: 5211-5221.
Xystrakis E, Kusumakar S, Boswell S .Reversing the defective induction on IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J ClinInvest 2006; 116:146-155.
Adorini L, Giarratana N, Penna G Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 2004; 16: 127-134.
Griffin MD, Xing N, Kumar R. Gene expression profiles in dendritic cells conditioned by 1alpha,25-dihydroxyvitamin D3 analog. J SteroidBiochem Mol Biol 2004; 89-90
Weiss ST .Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy ClinImmunol 2011; 127: 1128-1130.
Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF.1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-4980.
. Arnson Y, Amital H, Shoenfeld Y .Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142.
Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M .Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102: 3314- 3316.
Bouillon R, Bischoff-Ferrari H, Willett W .Vitamin D and health: perspectives from mice and man. J Bone Miner Res 2008; 23: 974-979.
Aguado P, del Campo MT, Garces MV, Gonzalez-Casuas ML, Bernad M, et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporosis Int 2000; 11: 739-744
Oelzner P, Muller A, Deschner F, Holler M, Abendroth K .Relationship between disease activity and serum levels of vitamin D
metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998; 62:193-198.
Jahnsen J, Falch JA, Mowinckel P, Aadland E .Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 192-199.
Nieves J, Cosman F, Herbert J, Shen V, Lindsay R .High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 1994. 44: 1687-1692.
Song GG, Bae SC, Lee YH .Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin Rheumatol 2012; 31: 1733-1739.
Brig MN, Chatterje A and Shinde R, "text book medical biochemistry", 6th ed. Published by jitendar prij 2005, 178-557.
Sahebari M, Ayati R, Mirzaei H, Sahebkar A, Hejazi S, Saghafi M, et al. Serum Trace Element Concentrations in Rheumatoid Arthritis. Biol Trace Elem Res. 2016;171(2):237-245.
Dehghan A, Rahimpour S, Soleymani-Salehabadi H, Owlia MB . Role of vitamin D in flare ups of rheumatoid arthritis. Zeitschrift for Rheumatologie. 2014;73: 461-464.
Zold, E.,P. Szodoray, J. Gaal .Vitamin D deficiency in undifferentiated connective tissue disease,” Arthritis Research & Therapy 2008; 10(5) R123.
Hewison, M., L. Freeman, S. V. Hughes “Differential regulation of vitamin D receptor and its ligand in human monocytederived dendritic cells,” Journal of Immunology 2003; 170( 11) : 5382–5390.
Weiss, S. Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic? J Allergy Clin Immunol 2011; 127: 1128–1130.
Hewison, M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl 2012; 243: 92–102.
Bartels, L., Hvas, C., Agnholt, J., Dahlerup, J. and Agger, R. Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 2010; 10: 922–928.
Chen, S., Sims, G., Chen, X., Gu, Y., Chen, S. and Lipsky, P. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007; 179: 1634–1647.
Hasan E, Olusi S, Al-Awadhi A, Mokaddem K, Sharma P, George S.Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis. Biologics: targets & therapy. . 2012; 6:31–5.
Merlino L, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis. Results from the Iowa Women’s Health Study. Arthr Rheumat. 2004; 50:72-7.
Attar SMVitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med J . 2012;33:520-5.
Sabbagh Z, Markland J, Vatanparast H. Vitamin D status is associated with disease activity among rheumatology outpatients. Nutrients 2013; 5:2268-75.
Kareem MI, Mohammed RH, Abozaid HS, Rayan MM, Mohamed AM, Fathi NA. Hypo-vitaminosis D in patients with rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis. J Clin Cell Immunol. 2015; 6:1-6
Yagiz AE, Ustun N, Paksoy H, Ustun I, Mansuroglu A, Guler H, Association of Vitamin D with disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Anal Med 2015;6:486-9.
Brig MN, Chatterje A and Shinde R, "text book medical biochemistry", 6th ed. Published by jitendar prij 2005, 178-557.
. Jonathan CL, ” Trace Elements in the fetus and young Infant, Copper, Manganese, Selenium and Chromium" Am. J. Dis.Child 1981; 134: 74-81.
. Carl AB and Edward RA “ Tietz Fundamentals of Clinical Chemistry”, 6th Ed., Saunders an imprint of Elsevier 2008, 496-507.
Ferestein GS, Larry A, Cruz TF, Cheng TP, Banqueriso ML and Boyle DL "Vanadium an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis" J. Rheumatology 2007; 34(9): 1802-1809.
. Hathcock JN, "Vitamins and minerals safety", 2nd ed. 2004, 35-49.
. Cerhan JR, Saag KG and Criswell LA. “Antioxidant Micronutrients and Risk of Rheumatoid Arthritis in Cohort of Older women” Am. J. Epidemiol 2003; 157(4): 345-354.
. Satish KT and Reshu M, “Assessment of mineral status (Zn, Cu, Mg and Mn) in Rheumatoid Arthritis patients in Chandigarh, India”, Rheumatology Report 2009,1(5):16-20.
De Carvalho PR, GonÇalves Pita MC, Loureiro JE, Tanaka HR and Ribeiro JS, “Manganese Deficiency in Bovines: connection between Manganese metalloenzyme Dependent in Gestation and Congenital Defects in New born Calves”, Pakistan Journal of Nutrition 2010, 9(5): 488-503.
. Santamaria AB. “Manganese Exposure, Essentiality and toxicity” Indian J.Medzres 2003; 128: 484-500.
. Spiewak R, Pietowska J and Curzytek K. “ Nickel: a unique allergic from molecular structure to European legislation, Epert Rev. Immunol. 2007; 3(6): 851-859.
. Cempel M and Nikel G. ” Nickel: Review of its sources and EnvIronmental Toxicology”, polish J. of EnvIron. Stud. 2006; 15(3): 375-382. [48]-Sahebari M, Ayati R, Mirzaei H, Sahebkar A, Hejazi S, Saghafi M, Saadati N, Ferns GA, Ghayour-Mobarhan M Serum trace element concentrations in rheumatoid arthritis. Biol Trace Elem Res 2016; 171(2):237–245 .
Afridi HI, Kazi TG, Kazi N, Talpur FN, Shah F, Naeemullah Evaluation of status of arsenic, cadmium, lead and zinc levels in biological samples of normal and arthritis patients of age groups (46-60) and (61-75) years. Clin Lab 2013; 59(1–2):143–153.
. XinL,YangX,CaiG,FanD,XiaQ,LiuL,HuY,et al .Serum levels of copper and zinc in patients with rheumatoid arthritis: a meta-analysis. Biol Trace Elem Res 2015;168(1):1–10